Heartflow (NASDAQ:HTFL) Shares Break Below Fifty Day Moving Average – Here’s Why

Shares of Heartflow, Inc. (NASDAQ:HTFL) passed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $51.91 and traded as low as $48.27. Heartflow shares last traded at $48.46, with a volume of 3,705,135 shares traded.

More Heartflow News

Investors following HTFL have been watching these news items:

• Positive Sentiment: Q3 revenue rose 57% year over year to $72.9 million, above the roughly $65.2 million consensus. The quarterly loss was $0.03 per share, narrower than analysts’ expected $0.18 loss and the $0.27 loss a year earlier. Q3 results
• Positive Sentiment: Heartflow raised its 2026 revenue guidance to $262 million–$264 million, above the approximately $248.5 million consensus, signaling stronger expected growth. Financial results and guidance
• Negative Sentiment: A report said Heartflow’s CEO sold about $2.17 million worth of stock. Insider selling can concern investors, though the report alone does not establish the reason for the sale. CEO stock sale

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Stifel Nicolaus upped their price objective on Heartflow from $45.00 to $70.00 and gave the company a “buy” rating in a research note on Friday. Wells Fargo & Company lifted their target price on Heartflow from $39.00 to $70.00 and gave the stock an “overweight” rating in a research report on Friday. Piper Sandler reiterated an “overweight” rating and issued a $64.00 target price (up from $45.00) on shares of Heartflow in a research report on Tuesday, October 20th. UBS Group started coverage on Heartflow in a report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 price target for the company. Finally, Benchmark reissued a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $60.12.

Heartflow Trading Down 19.1%

The stock’s 50-day moving average price is $51.91 and its 200-day moving average price is $35.23. The company has a market capitalization of $4.21 billion, a P/E ratio of -52.67 and a beta of 2.50.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Thursday, November 12th. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.15. Heartflow had a negative net margin of 33.11% and a negative return on equity of 20.42%. The business had revenue of $72.86 million during the quarter. During the same period in the prior year, the company earned ($0.27) EPS. Sell-side analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Heartflow news, CFO Vikram Verghese sold 29,714 shares of Heartflow stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $50.06, for a total value of $1,487,482.84. Following the completion of the transaction, the chief financial officer directly owned 184,789 shares in the company, valued at $9,250,537.34. The trade was a 13.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 23,933 shares of the company’s stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total value of $1,316,554.33. Following the transaction, the insider directly owned 73,453 shares of the company’s stock, valued at $4,040,649.53. This trade represents a 24.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 332,403 shares of company stock valued at $16,602,786 over the last quarter. Insiders own 7.70% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. XXEC Inc. bought a new position in Heartflow during the 2nd quarter worth $2,524,764,000. BlackRock Inc. bought a new stake in Heartflow in the second quarter valued at $152,502,000. Bamco Inc. NY bought a new stake in Heartflow in the second quarter valued at $94,625,000. Jupiter Topco LLC bought a new stake in Heartflow in the second quarter valued at $70,983,000. Finally, Janus Henderson Group PLC boosted its holdings in shares of Heartflow by 152.0% during the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after acquiring an additional 1,315,416 shares during the period.

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.